SARS-CoV2 main protease inhibitors

The present disclosure relates to compounds of Formula I: and pharmaceutically acceptable salts thereof, pharmaceutical compositions thereof, useful in the treatment of treating viral infections, for example, coronaviridae infections.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	MCKINLEY, JESSICA L, RODRIGUEZ, KEVIN X, SWANK, CHRISTOPHER J, KINFE, HENOK H, VAN VELDHUIZEN, JOSHUA J, CAI, XIN-PEI, CANALES, EDA Y, MISH, MICHAEL R, CHIN, GREGORY F, NADUTHAMBI, DEVAN, PERRY, JASON K, SCHROEDER, SCOTT D, AMMANN, STEPHEN E, LAZERWITH, SCOTT E, CHANG, WENG K
Format:	Patent
Sprache:	chi ; eng
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present disclosure relates to compounds of Formula I: and pharmaceutically acceptable salts thereof, pharmaceutical compositions thereof, useful in the treatment of treating viral infections, for example, coronaviridae infections.